Back to Search
VARALAKSHMI JANAMANCHI, M.D.
M.D.
Internal Medicine Physician
NPI: 1255532891IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
35095410(OH)
Education
OTHER
Class of 2000
Research & Publications (4)
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
PMID 19318576·Cancer Res·2009
7-preclinical
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
PMID 18172305·Cancer Res·2008
7-preclinical
c-Met is a potentially new therapeutic target for treatment of human melanoma.
PMID 17404109·Clin Cancer Res·2007
8-other
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
PMID 16397249·Cancer Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE, SUITE RC25
CLEVELAND, OH 44195 - Phone
- (216) 444-2200
Quick Facts
- NPI
- 1255532891
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 4
Are you this provider?
Claim Your Profile